Recombinant SIRPα Protein Expression and Purification
Corresponding Organization :
Other organizations : Collaborative Drug Discovery (United States), The University of Texas Southwestern Medical Center
Variable analysis
- Expression culture conditions (5 days at 37 °C in 8% CO2)
- Antibody expression levels
- Protein purification efficiency
- Expi293 cell line used for expression
- Manufacturer's protocol for antibody expression
- Affinity purification using MabSelect Sure LX resin
- Ni-Sepharose 6 Fast Flow affinity purification and gel filtration for SIRPα IgV domain proteins
- Fab fragment generation for crystallography
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!